The hottest Biotechnology Substack posts right now

And their main takeaways
Category
Top Science Topics

A Little More Roche Information...

ASeq Newsletter β€’ 21 implied HN points β€’ 29 Jan 25
πŸ”¬ Science Biotechnology
  1. Roche is developing a new nanopore sequencer, which is creating some buzz in the scientific community. People are eager to hear more about its features and capabilities.
  2. Alex Dickinson shared his thoughts on Roche's new sequencer after a private briefing. His insights mostly echoed what is already known but added some new expectations for the upcoming announcement.
  3. A few individuals, including the author, have decided to skip NDA previews, allowing them to speculate freely about the product. This has led to informal discussions and excitement about what might be revealed soon.

Something Up At Oxford Nanopore?

ASeq Newsletter β€’ 29 implied HN points β€’ 08 Nov 24
πŸ”¬ Science Biotechnology
  1. There are rumors that Clive Brown might have left Oxford Nanopore, but it's not confirmed. It's important to check and verify such news before spreading it.
  2. Investment opportunities for Oxford Nanopore were discussed earlier, suggesting potential growth for the company. Keeping an eye on funding can indicate how the company might progress.
  3. The information shared is meant for paid subscribers, highlighting the value of the insights provided. Paid content often offers deeper analysis and exclusive news.

Links in Progress: Snakebites, Pig Hearts, and More

The Works in Progress Newsletter β€’ 19 implied HN points β€’ 03 Feb 25
πŸ”¬ Science Biotechnology
  1. An AI tool has been developed to create a new kind of antivenom that can work without refrigeration. This could help save many lives, especially in areas where snakebites are common.
  2. A study showed that a vaccine for Ebola had an 84% effectiveness in preventing the disease in high-risk groups. This is good news for controlling future outbreaks.
  3. New technologies in gene editing and drug development are rapidly evolving, with Chinese companies making significant strides in creating new treatments.

Landscape of Sequencing-based Spatial RNA Technology

LatchBio β€’ 15 implied HN points β€’ 27 Feb 25
πŸ•Ή Technology Biotechnology
  1. Spatial RNA technology helps us see how cells interact in their natural environment. It gives a clearer picture than traditional methods that just show gene activity without their locations.
  2. There are many ways to capture and analyze spatial gene data, like using specially barcoded slides or microfluidic methods. Each approach has its pros and cons depending on what researchers want to study.
  3. Advancements in technology are making it possible to analyze tiny details, like individual cells or even parts of cells. This opens new doors for understanding biology and diseases.

Codon Digest: GPT-4 Controls a Robot

Asimov Press β€’ 90 implied HN points β€’ 16 Apr 23
πŸ”¬ Science Biotechnology
  1. GPT-4 controlled a lab robot to conduct chemical reactions, showcasing the potential of using natural language to automate experiments.
  2. Skin microbes were engineered to activate the immune system to fight tumors when applied to the skin, offering a novel cancer treatment approach.
  3. Tobacco plants were genetically modified to produce moth sex pheromones, providing a natural way to repel male moths from crops and protect them.
Get a weekly roundup of the best Substack posts, by hacker news affinity:

Synthesis - Switchback Systems, Inc.

ASeq Newsletter β€’ 7 implied HN points β€’ 04 Jul 25
πŸ”¬ Science Biotechnology
  1. Switchback Systems appears to own some interesting technology but isn't using it in the expected way. Instead of focusing on protein sequencing, they're exploring a new method for synthesis.
  2. There's some confusion about the direction of Switchback Systems because they don't seem to align with the typical work associated with their intellectual property.
  3. The discussion highlights the importance of understanding how companies adapt their technologies and where they might lead in the future.

Will Oxford Nanopore Sue Roche?

ASeq Newsletter β€’ 14 implied HN points β€’ 25 Feb 25
πŸ”¬ Science Biotechnology
  1. Oxford Nanopore has been actively suing companies like BGI without concrete claims of intellectual property infringement. This raises questions about their legal strategy.
  2. Roche might also face issues if they used Oxford's sequencers, especially since there are user agreements involved that they might have overlooked.
  3. Oxford Nanopore has a history of using the hairpin duplex approach, which led to legal disputes in the past. It will be interesting to see if their current patents hold up against previous art from competitors.

Rationalizing The Illumina Instrument Lineup

ASeq Newsletter β€’ 51 implied HN points β€’ 09 Jan 24
πŸ•Ή Technology Biotechnology
  1. Illumina has a variety of sequencing instruments in their lineup, which includes different models and variations.
  2. The cost of production for these instruments varies based on the technology and components used.
  3. Rationalizing the Illumina instrument lineup could involve withdrawing some current models and introducing new, more cost-effective options.

The Roche Nanopore Chip

ASeq Newsletter β€’ 14 implied HN points β€’ 21 Feb 25
πŸ”¬ Science Biotechnology
  1. The Roche Nanopore Chip provides a lot of information that needs careful examination. It's important to figure out its size and costs.
  2. The sensor module of the chip can be reused over 10 times, which could be cost-effective.
  3. There is a lot of potential in the technology, and understanding it fully will take some time.

All The DNA Sequencing Companies

ASeq Newsletter β€’ 14 implied HN points β€’ 17 Feb 25
πŸ”¬ Science Biotechnology
  1. There are many active DNA sequencing companies, and the list is always changing. Some companies that were once popular are now gone.
  2. Significantly, more DNA sequencing companies are now based in China than before. The landscape has shifted with around 15 out of 40 companies being Chinese.
  3. It's essential to stay updated about these companies as new ones emerge and old ones disappear. Sharing information can help keep track of these changes.

Another Nanopore: PolySeq

ASeq Newsletter β€’ 14 implied HN points β€’ 16 Feb 25
πŸ”¬ Science Biotechnology
  1. PolySeq is creating a new DNA/RNA sequencing tool similar to the Oxford Nanopore. It aims to improve how we sequence genetic materials.
  2. The device weighs 1.5 kilograms and can handle 2560 wells or pores. This design helps it generate a lot of data in a short time.
  3. PolySeq plans to produce 15 to 20 gigabytes of data in just 48 hours, making sequencing faster and more efficient.

The PacBio Vega - More Tech Details

ASeq Newsletter β€’ 21 implied HN points β€’ 07 Nov 24
πŸ•Ή Technology Biotechnology
  1. The PacBio Vega is designed for small labs and minimizes downtime between runs. Users can load new samples while a run is ongoing, making it efficient.
  2. The technology in the Vega seems to be similar to the Revio but aims to reduce costs, likely making high-quality sequencing more accessible to small research centers.
  3. There's curiosity about how PacBio has managed to incorporate advanced computing power into a compact design, which is crucial for producing quality data without needing expensive equipment.

Acorn Genetics

ASeq Newsletter β€’ 14 implied HN points β€’ 13 Feb 25
πŸ”¬ Science Biotechnology
  1. Acorn Genetics is working on a new type of DNA sequencing technology. This technology promises to be fast, giving results in just minutes.
  2. The platform aims to be affordable, costing less than $10,000, which could make it accessible to more users.
  3. One of the cool features is that it won’t require any training to use, meaning anyone could operate it easily.

The PromethION...

ASeq Newsletter β€’ 7 implied HN points β€’ 13 Jun 25
πŸ”¬ Science Biotechnology
  1. The PromethION flowcell might have a lower cost of goods sold compared to the MinION. This could be a reason for its continued use despite falling sales of the MinION.
  2. There’s speculation about who is involved in making and designing the PromethION and its costs. Understanding this could shed light on its future.
  3. The author seems to question why Oxford is not considering cancelling the MinION given its declining sales, which shows concern for business decisions.

Keeping up with the State-of-the-Art in TechBio

Kesav’s Lab β€’ 12 implied HN points β€’ 21 Feb 25
πŸ•Ή Technology Biotechnology
  1. The Nobel Prize in Chemistry was awarded for breakthroughs in understanding protein structures, which can lead to better medicines and solutions to major health challenges.
  2. There’s a growing community focused on TechBio, which merges technology and biology. Events like meetups can help people learn and connect over important topics.
  3. Staying informed about the latest in TechBio is important, and contributing to community newsletters helps track new tools and research developments.

The HiSeq X Flowcell

ASeq Newsletter β€’ 43 implied HN points β€’ 18 Dec 23
πŸ”¬ Science Biotechnology
  1. About 30% of reagents may be wasted in dead volume on the HiSeq X Flowcell.
  2. The flowcell channels on the HiSeq X have a volume range of 15 to 20 uL.
  3. There could be significant cost implications if reagents costs are a large part of the sequencing expenses.

454.Bio And Reticula

ASeq Newsletter β€’ 43 implied HN points β€’ 21 Nov 23
πŸ”¬ Science Biotechnology
  1. Bio is working on a cheap and simple DNA sequencing platform
  2. Bio and Reticula both use evanescent fields to remove labels near the surface for sequencing
  3. Reticula has been ahead in the technology but patents might expire soon

Year In Review - Everything Else!

ASeq Newsletter β€’ 14 implied HN points β€’ 20 Dec 24
πŸ”¬ Science Biotechnology
  1. Clinical sequencing is becoming a major part of the medical field, especially in areas like oncology and genetic disease testing. However, many clinicians still find it challenging to use these new testing methods.
  2. Protein sequencing is an emerging area with potential advancements on the horizon, particularly with new technologies like Nanopore. It's an exciting field that many are watching closely.
  3. Single cell analysis remains a hot topic, but companies like 10X Genomics are facing challenges with growth and patent issues. There are still many experiments and innovations happening in this space.

4 Reads Per Cluster! Simultaneously Paired End-Sequencing!

ASeq Newsletter β€’ 36 implied HN points β€’ 31 Jan 24
πŸ”¬ Science Biotechnology
  1. Illumina has a method to potentially double their instruments' throughput, but it may come with a slight decrease in accuracy.
  2. By simultaneously reading both the forward and reverse strands, Illumina can achieve four reads per cluster, doubling the throughput.
  3. Implementing the simultaneous paired-end sequencing approach may be challenging without sacrificing accuracy, but it opens up opportunities for increased throughput in the future.

Biomemory - Enzymatic Data Storage

ASeq Newsletter β€’ 14 implied HN points β€’ 11 Dec 24
πŸ•Ή Technology Biotechnology
  1. A French startup called Biomemory has raised $18 million for its new enzymatic data storage technology. This is surprising because other companies in the same field are struggling.
  2. Biomemory's first product includes a card that can encode data into DNA, specifically a message of 'Hello World!' using a unique encoding method. This method has some inefficiencies, as it uses more bases than necessary.
  3. The startup faces challenges with encoding data, particularly with homopolymers, which might complicate their technology. Future developments could look into improving these encoding issues.

Why Does Cluster Generation Take 5HOURS!?

ASeq Newsletter β€’ 51 implied HN points β€’ 25 Jul 23
πŸ”¬ Science Biotechnology
  1. Cluster generation time by Illumina seems to be increasing across various instruments.
  2. Illumina aims to increase cluster template density for smaller clusters and reduced imaging time.
  3. Various patents suggest methods used by Illumina to boost primer density and template density in clusters.

You can now run single-cell experiments in a tube with 4.5 hours of hands-on time

LatchBio β€’ 12 implied HN points β€’ 26 Dec 24
πŸ•Ή Technology Biotechnology
  1. A new single-cell sequencing technology makes experiments easier and faster, only needing about 4.5 hours of hands-on work. This means more scientists can do these experiments without needing a big budget or lots of extra equipment.
  2. The new method allows for better scalability, letting researchers run from 1 to 96 samples easily. This flexibility can lead to more data and insights in various experiments, such as drug development or studying disease.
  3. The SimpleCell technology also includes user-friendly analysis tools, making it easier for scientists to understand and visualize their results. This helps them feel more in control of their research and get valuable insights quickly.

More Nanopore Nonsense...

ASeq Newsletter β€’ 14 implied HN points β€’ 08 Nov 24
πŸ”¬ Science Biotechnology
  1. Clive Brown has left Oxford Nanopore, and there are mixed reports about his last day at the company.
  2. Oxford Nanopore attempted to prevent Estonia from acquiring PacBio sequencers for a population sequencing project.
  3. The details of the dispute regarding the sequencers can be found in a public document shared by a user on Discord.

The PacBio Benchtop - The Vega

ASeq Newsletter β€’ 14 implied HN points β€’ 07 Nov 24
πŸ•Ή Technology Biotechnology
  1. The new PacBio Vega is a benchtop DNA sequencer that provides 60Gb of data in just 24 hours and costs $169,000. There's also a lower cost option for labs that need less capacity.
  2. When compared to Oxford Nanopore's PromethION, the Vega appears to deliver better accuracy and more consistent results, making it a suitable choice for smaller labs needing reliable output.
  3. The launch of the Vega could help PacBio increase revenue and broaden its market presence, as it appeals to labs that want access to high-quality sequencing without breaking the bank.

Issue 17: No great stagnation in cruise ships

The Works in Progress Newsletter β€’ 12 implied HN points β€’ 05 Dec 24
πŸ•Ή Technology Biotechnology
  1. Cruise ships show that new ideas and growth are still possible in design and urban living, even as some land technologies seem to stall.
  2. Madrid has successfully built its metro system much faster and cheaper than cities like London and New York by using smart planning and incentives for local leaders.
  3. Many animals, like horses and crabs, are essential for creating life-saving chemicals, reminding us that we still rely on nature, even as technology advances.

The ultra-selfish gene

The Works in Progress Newsletter β€’ 13 implied HN points β€’ 08 Nov 24
πŸ”¬ Science Biotechnology
  1. Gene editing technology, especially CRISPR/Cas9, offers powerful ways to potentially eliminate malaria by modifying the mosquitoes that spread it. This could save millions of lives.
  2. Selfish genetic elements can alter inheritance patterns within populations, which may allow a single gene edit to spread rapidly through an entire species, potentially causing significant ecological changes.
  3. While gene drives could provide solutions to public health issues, their release carries risks. There’s a need for careful monitoring and potential reversal strategies to prevent unintended consequences.

The Cloud for Biology

LatchBio β€’ 39 implied HN points β€’ 29 Aug 23
πŸ”¬ Science Biotechnology
  1. Storing and transferring large sequencing files in biology can be challenging due to the lack of user-friendly storage solutions like AWS S3.
  2. Integrating and tracking sample metadata in biology is vital but often hindered by unintuitive systems and lack of system integrations.
  3. Setting up data pipelines and computational workflows for biology data analysis is labor-intensive, requiring user-friendly interfaces and tools.

Roche Nanopore: Accuracy

ASeq Newsletter β€’ 7 implied HN points β€’ 28 Feb 25
πŸ”¬ Science Biotechnology
  1. Roche's Q39 accuracy system is different from other platforms like Illumina and Oxford Nanopore. It's important to compare them carefully as each has unique metrics.
  2. The average accuracy of different sequencing platforms varies, but Roche doesn't provide clear comparisons. They share limited data about their simplex accuracy.
  3. Understanding the differences in data quality and error rates across platforms is crucial. Factors like read length and error filtering play a significant role in the accuracy of sequencing results.

NobleGen

ASeq Newsletter β€’ 7 implied HN points β€’ 10 Feb 25
πŸ”¬ Science Biotechnology
  1. Noblegen focused on an optical nanopore DNA sequencing method, but they are no longer active. This approach has been attempted multiple times with limited success.
  2. They incorporated a technique where each DNA base is replaced with multiple bases to simplify detection, but there's not much strong evidence that this method works well.
  3. The Noblegen Optipore method showed promise in development, but it was ultimately not adopted, reflecting the challenges in the field of DNA sequencing technology.

Tectonic Therapeutic: Protein Engineering and Fc-relaxin for Hypertension

Axial β€’ 7 implied HN points β€’ 31 Jan 25
πŸ₯ Health & Wellness Biotechnology
  1. Tectonic Therapeutic focuses on protein engineering to help treat hypertension. This means they are working on new medical treatments using proteins to effectively lower blood pressure.
  2. Axial invests in early-stage life sciences companies. They are particularly interested in supporting new ideas and inventions that can grow to make a big impact in healthcare.
  3. Support for inventors is a key part of Axial's mission. They aim to help those who are passionate about creating lasting solutions in the life sciences field.

Synthetic integrin antibodies discovered by yeast display reveal Ξ±V subunit pairing preferences with Ξ² subunits

Axial β€’ 7 implied HN points β€’ 31 Jan 25
πŸ”¬ Science Biotechnology
  1. New antibodies were created that can specifically block integrins, which are important for cell functions like attachment and signaling. This may lead to better treatments for diseases.
  2. Researchers found that different Ξ² subunits bind preferentially to the Ξ±V subunit in integrins. Understanding these pairings helps explain how integrins work in the body.
  3. The antibodies developed through this study can directly compete with small molecules that normally bind to integrins. This opens the door for more precise therapies in the future.

What The H*ll Is PPMSeq?

ASeq Newsletter β€’ 21 implied HN points β€’ 17 Feb 24
πŸ”¬ Science Biotechnology
  1. PPMSeq is a duplex sequencing technique that ensures high accuracy reads by reading both forward and reverse strands of a double-stranded sequence.
  2. Ultima's PPMSeq works by amplifying both strands on the same bead and utilizing a tag to identify their presence, with errors causing radical dephasing which is taken care of by downstream software.
  3. Approaches to implementing PPMSeq on Ultima's platform involve reading both strands in both directions simultaneously or keeping the product on beads in the same orientation, each with its own challenges and considerations.

Ultima Genomics

ASeq Newsletter β€’ 7 implied HN points β€’ 17 Jan 25
πŸ”¬ Science Biotechnology
  1. Ultima Genomics is making progress, but there are doubts about their ability to meet demand.
  2. They have created a large dataset of 100 million cells with Vevo Therapeutics using new technology.
  3. The community is actively discussing their projects and updates to stay informed.

PacBio@JPM - Tech Stuff

ASeq Newsletter β€’ 7 implied HN points β€’ 15 Jan 25
πŸ•Ή Technology Biotechnology
  1. PacBio is working on high-density chips that can hold more information than before. This means they can process data faster and more efficiently.
  2. The focus on ongoing technical development indicates that PacBio is trying to stay ahead in the biotech field. They are continuously improving their technology to meet market needs.
  3. The information presented is part of a broader update at the JPM conference, showing that PacBio is committed to advancing their technology and sharing their progress with subscribers.

Genopore - Nanopore Protein Detection

ASeq Newsletter β€’ 7 implied HN points β€’ 08 Jan 25
πŸ”¬ Science Biotechnology
  1. Genopore is an Israeli company focused on a new way to detect proteins. They are more interested in detection methods rather than just fingerprinting or sequencing proteins.
  2. The technology they are developing is considered novel, suggesting it could bring new advancements to protein detection.
  3. Their patents and website indicate they have a clear direction towards enhancing protein detection capabilities.

DNA foundation modeling

Axial β€’ 7 implied HN points β€’ 10 Dec 24
πŸ”¬ Science Biotechnology
  1. DNA foundation models are helping scientists analyze and understand the complex patterns in genetic data. They can lead to important discoveries in medicine and biology.
  2. Building these models is tough because DNA sequences are long and complicated. Special techniques are needed to process them efficiently and recognize important details.
  3. While these models have great potential, they need to be tested carefully to avoid mistakes. We also need to think about the ethical implications of using them in research and medicine.

Year In Review - Long Reads

ASeq Newsletter β€’ 7 implied HN points β€’ 18 Dec 24
πŸ•Ή Technology Biotechnology
  1. PacBio faced challenges in the stock market but still aims to provide high-quality clinical genomic sequencing. They are seen as a strong competitor in the long-read space despite financial struggles.
  2. Oxford Nanopore has been active in raising funds but has dealt with internal issues and departures of significant team members. Profitability remains an elusive goal for both them and PacBio.
  3. New competitors are emerging in the long-read sequencing market, including Roche and BGI, who are exploring nanopore sequencing technology. This could shake up the landscape for current players.